Immunotherapy Safety for the Primary Care ... - U.S. Coast Guard
Immunotherapy Safety for the Primary Care ... - U.S. Coast Guard
Immunotherapy Safety for the Primary Care ... - U.S. Coast Guard
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Date _______________<br />
______________ CLINIC<br />
Standard Operating Procedures<br />
IMMUNOTHERAPY<br />
1. Purpose: This operating instruction provides procedures to follow when administering<br />
immuno<strong>the</strong>rapy.<br />
2. Responsibility: All assigned Clinic personnel.<br />
3. References:<br />
a. Allergen immuno<strong>the</strong>rapy: a practice parameter. Ann Allergy Asthma Immunol. 2003<br />
Jan;90(1 Suppl 1):1-40.<br />
b. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy<br />
Clin Immunol. 2005 Mar;115(3 Suppl 2):S483-523<br />
4. General:<br />
a. <strong>Immuno<strong>the</strong>rapy</strong> (AIT) is initiated by <strong>the</strong> prescribing Allergist whose name and contact<br />
in<strong>for</strong>mation will be readily available to all clinic staff. By design, <strong>the</strong> patient will arrive at <strong>the</strong><br />
clinic with an allergen extract kit (allergy shot vials) that has originated from ano<strong>the</strong>r<br />
facility/provider. The vials and accompanying documentation will be reviewed by <strong>the</strong> ____<br />
Clinic’s Physician-In-Charge assuring adherence to established standards to ensure<br />
appropriateness and safety be<strong>for</strong>e <strong>the</strong> patient receives his/her AIT. The prescribing Allergist is<br />
responsible <strong>for</strong> providing AIT extracts labled IAW Ref. (a), protocols <strong>for</strong> AIT administration and<br />
alteration in dosing in <strong>the</strong> event of an adverse reaction or missed doses, and <strong>for</strong> providing point<br />
of contact in<strong>for</strong>mation. Allergen immuno<strong>the</strong>rapy can be temporarily withheld without placing<br />
<strong>the</strong> patient at undue risk.<br />
b. An Allergy Treatment Record will be maintained on all patients receiving AIT in <strong>the</strong><br />
Clinic. All AIT injections, reactions (immediate and delayed), and alterations in dosing will be<br />
recorded in this record. This record will contain <strong>the</strong> signed in<strong>for</strong>med consent, Problem Summary<br />
List, AIT prescription, AIT administration instructions, AIT Adjustment protocol, name and<br />
contact in<strong>for</strong>mation of <strong>the</strong> prescribing Allergist.<br />
c. Prior to beginning AIT, all patients or, in <strong>the</strong> case of a minor, <strong>the</strong> parent or legal guardian,<br />
will review/complete and sign all required <strong>for</strong>ms including <strong>the</strong> in<strong>for</strong>med consent, patient<br />
instruction sheet, and <strong>the</strong> problem list. In general, allergy shots will not be administered to<br />
patients on Beta blockers. Any patient on Beta blockers will have <strong>the</strong>ir shots withheld and will<br />
be referred to <strong>the</strong> Physician-In-Charge <strong>for</strong> fur<strong>the</strong>r consultation with <strong>the</strong> prescribing Allergist.<br />
d. All persons under 18 years of age must be accompanied by a parent/legal guardian.<br />
5. Patient Instructions:<br />
a. The Clinic’s nurse/technician will instruct <strong>the</strong> patient about what is expected when AIT is<br />
begun.<br />
b. The patient will be in<strong>for</strong>med that <strong>the</strong> allergen extract(s) will be maintained at <strong>the</strong> ________<br />
Clinic. Patients will not be allowed to maintain <strong>the</strong>ir allergy extracts in <strong>the</strong>ir home.